BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 31841257)

  • 21. Cardiac MRI for the evaluation of oncologic cardiotoxicity.
    Löffler AI; Salerno M
    J Nucl Cardiol; 2018 Dec; 25(6):2148-2158. PubMed ID: 29736616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease.
    Totzeck M; Schuler M; Stuschke M; Heusch G; Rassaf T
    Int J Cardiol; 2019 Apr; 280():163-175. PubMed ID: 30661849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer Therapeutics-Related Cardiac Dysfunction - Insights From Bench and Bedside of Onco-Cardiology.
    Kadowaki H; Akazawa H; Ishida J; Komuro I
    Circ J; 2020 Aug; 84(9):1446-1453. PubMed ID: 32727978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving paediatric cardiologists' awareness about the needs of childhood cancer survivors: results of a single-centre directed educational initiative.
    Rose-Felker K; Effinger K; Kelleman MS; Sachdeva R; Meacham LR; Border WL
    Cardiol Young; 2019 Jun; 29(6):808-812. PubMed ID: 31280730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction.
    Demissei BG; Hubbard RA; Zhang L; Smith AM; Sheline K; McDonald C; Narayan V; Domchek SM; DeMichele A; Shah P; Clark AS; Fox K; Matro J; Bradbury AR; Knollman H; Getz KD; Armenian SH; Januzzi JL; Tang WHW; Liu P; Ky B
    J Am Heart Assoc; 2020 Jan; 9(2):e014708. PubMed ID: 31959034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics-Related Cardiac Dysfunction.
    Narayan HK; French B; Khan AM; Plappert T; Hyman D; Bajulaiye A; Domchek S; DeMichele A; Clark A; Matro J; Bradbury A; Fox K; Carver JR; Ky B
    JACC Cardiovasc Imaging; 2016 Oct; 9(10):1131-1141. PubMed ID: 27085442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic Imaging in Cardio-oncology.
    Tong D; Zaha VG
    J Cardiovasc Transl Res; 2020 Jun; 13(3):357-366. PubMed ID: 31696405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global Initiative.
    Teske AJ; Moudgil R; López-Fernández T; Barac A; Brown SA; Deswal A; Neilan TG; Ganatra S; Abdel Qadir H; Menon V; Sverdlov AL; Cheng RK; Makhoul S; Ghosh AK; Szmit S; Zaha V; Addison D; Zhang L; Herrmann J; Chong JH; Agarwala V; Iakobishvili Z; Guerrero P; Yang EH; Leja M; Akhter N; Guha A; Okwuosa TM; Silva CC; Collier P; DeCara J; Bauer B; Lenneman CE; Sadler D
    Circ Cardiovasc Qual Outcomes; 2023 Oct; 16(10):e009905. PubMed ID: 37702048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric Cardio-Oncology: Development of Cancer Treatment-Related Cardiotoxicity and the Therapeutic Approach to Affected Patients.
    Ryan TD; Nagarajan R; Godown J
    Curr Treat Options Oncol; 2019 May; 20(7):56. PubMed ID: 31129800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Utility of Cardiac Reserve for the Early Detection of Cancer Treatment-Related Cardiac Dysfunction: A Comprehensive Overview.
    Foulkes S; Claessen G; Howden EJ; Daly RM; Fraser SF; La Gerche A
    Front Cardiovasc Med; 2020; 7():32. PubMed ID: 32211421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Profile and Prognosis of a Real-World Cohort of Patients With Moderate or Severe Cancer Therapy-Induced Cardiac Dysfunction.
    Esteban-Fernández A; Carvajal Estupiñan JF; Gavira-Gómez JJ; Pernas S; Moliner P; Garay A; Sánchez-González Á; Fernández-Rozas I; González-Costello J
    Front Cardiovasc Med; 2021; 8():721080. PubMed ID: 34778393
    [No Abstract]   [Full Text] [Related]  

  • 32. The Role of Biomarkers in Cardio-Oncology.
    Ananthan K; Lyon AR
    J Cardiovasc Transl Res; 2020 Jun; 13(3):431-450. PubMed ID: 32642841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating biomarkers for management of cancer therapeutics-related cardiac dysfunction.
    Tonry C; Russell-Hallinan A; McCune C; Collier P; Harbinson M; Dixon L; Watson CJ
    Cardiovasc Res; 2023 May; 119(3):710-728. PubMed ID: 35640873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).
    Čelutkienė J; Pudil R; López-Fernández T; Grapsa J; Nihoyannopoulos P; Bergler-Klein J; Cohen-Solal A; Farmakis D; Tocchetti CG; von Haehling S; Barberis V; Flachskampf FA; Čeponienė I; Haegler-Laube E; Suter T; Lapinskas T; Prasad S; de Boer RA; Wechalekar K; Anker MS; Iakobishvili Z; Bucciarelli-Ducci C; Schulz-Menger J; Cosyns B; Gaemperli O; Belenkov Y; Hulot JS; Galderisi M; Lancellotti P; Bax J; Marwick TH; Chioncel O; Jaarsma T; Mullens W; Piepoli M; Thum T; Heymans S; Mueller C; Moura B; Ruschitzka F; Zamorano JL; Rosano G; Coats AJS; Asteggiano R; Seferovic P; Edvardsen T; Lyon AR
    Eur J Heart Fail; 2020 Sep; 22(9):1504-1524. PubMed ID: 32621569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer: a multi-centre observational study.
    Skitch A; Mital S; Mertens L; Liu P; Kantor P; Grosse-Wortmann L; Manlhiot C; Greenberg M; Nathan PC
    BMC Cancer; 2017 Aug; 17(1):519. PubMed ID: 28774277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contemporary Role of Echocardiography for Clinical Decision Making in Patients During and After Cancer Therapy.
    Liu J; Banchs J; Mousavi N; Plana JC; Scherrer-Crosbie M; Thavendiranathan P; Barac A
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1122-1131. PubMed ID: 30092969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).
    Pituskin E; Haykowsky M; McNeely M; Mackey J; Chua N; Paterson I
    BMC Cancer; 2016 Sep; 16(1):733. PubMed ID: 27629548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concepts in cardio-oncology: definitions, mechanisms, diagnosis and treatment strategies of cancer therapy-induced cardiotoxicity.
    Wickramasinghe CD; Nguyen KL; Watson KE; Vorobiof G; Yang EH
    Future Oncol; 2016 Mar; 12(6):855-70. PubMed ID: 26829050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardio-Oncology for the Primary Care Provider.
    Jhawar N; Mcpherson A; Chirila R; Ray J
    Rom J Intern Med; 2023 Sep; 61(3):127-134. PubMed ID: 37249550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rehabilitation Needs in Cancer Treatment-Related Cardiotoxicity.
    Pituskin E; Kirkham AA; Cox-Kennett N; Dimitry R; Dimitry J; Paterson I; Gyenes GT
    Semin Oncol Nurs; 2020 Feb; 36(1):150986. PubMed ID: 31983487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.